Author/Creator: Nitta, Hiroaki - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Nitta, Hiroaki

1. Epidermal growth factor receptor mutation‐specific immunohistochemical antibodies in lung adenocarcinoma. Issue 6 (29th January 2014)

Authors:: Allo, Ghassan; Bandarchi, Bizhan; Yanagawa, Naoki; Wang, Ami; Shih, Warren; Xu, Jing; Dalby, Morgan; Nitta, Hiroaki; To, Christine; Liu, Ni; Sykes, Jenna; Tsao, Ming S
Journal:: Histopathology
Issue:: Volume 64:Issue 6(2014)
Page Start:: 826
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. HER2 Gene Protein Assay: A Robust Tool for Evaluating HER2 Status and Intratumoral Heterogeneity in Endometrial Cancers. Issue 5 (1st March 2023)

Authors:: Shafi, Saba; Nitta, Hiroaki; Shah, Manan; Challa, Bindu; Parwani, Anil V; Li, Zaibo
Journal:: American journal of clinical pathology
Issue:: Volume 159:Issue 5(2023)
Page Start:: 464
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Identification of HER2 Immunohistochemistry-Negative, FISH-Amplified Breast Cancers and Their Response to Anti-HER2 Neoadjuvant Chemotherapy. Issue 2 (18th October 2018)

Authors:: Gibbons-Fideler, I-sanna; Nitta, Hiroaki; Murillo, Adrian; Tozbikian, Gary; Banks, Peter; Parwani, Anil V; Li, Zaibo
Journal:: American journal of clinical pathology
Issue:: Volume 151:Issue 2(2019)
Page Start:: 176
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Intratumoral Estrogen Receptor Heterogeneity of Expression in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer as Evaluated by a Brightfield Multiplex Assay. (August 2019)

Authors:: Masuda, Shinobu; Nitta, Hiroaki; Kelly, Brian D.; Zhang, Wenjun; Farrell, Michael; Dennis, Eslie
Journal:: Journal of histochemistry and cytochemistry
Issue:: Volume 67:Number 8(2019:Aug.)
Page Start:: 563
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. PD‐L1 expression and CD8‐positive T cells are associated with favorable survival in HER2‐positive invasive breast cancer. Issue 6 (19th September 2018)

Authors:: Hou, Yanjun; Nitta, Hiroaki; Wei, Lai; Banks, Peter M; Lustberg, Maryam; Wesolowski, Robert; Ramaswamy, Bhuvaneswari; Parwani, Anil V.; Li, Zaibo
Journal:: Breast journal
Issue:: Volume 24:Issue 6(2018)
Page Start:: 911
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. The assessment of HER2 status and its clinical implication in breast cancer. Issue 2 (February 2020)

Authors:: Hou, Yanjun; Nitta, Hiroaki; Parwani, Anil V.; Li, Zaibo
Journal:: Diagnostic histopathology
Issue:: Volume 26:Issue 2(2020)
Page Start:: 61
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. The assessment of HER2 status in breast cancer: the past, the present, and the future. Issue 6 (7th April 2016)

Authors:: Nitta, Hiroaki; Kelly, Brian D.; Allred, Craig; Jewell, Suzan; Banks, Peter; Dennis, Eslie; Grogan, Thomas M.
Journal:: Pathology international
Issue:: Volume 66:Issue 6(2016)
Page Start:: 313
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗